Low LDL causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary Tag: mobile edit |
||
(6 intermediate revisions by 2 users not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Low LDL levels can be caused by unusual inherited disorders of lipoprotein metabolism such as [[abetalipoproteinemia]] and [[hypobetalipoproteinemia]]. | |||
==Causes== | ==Causes== | ||
Line 35: | Line 35: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[Clofibrate]], [[Colesevelam (patient information)|colesevelam hydrochlorie]], [[colestyramine]], [[doxazosin]], [[nicotinic acid]], [[NSAID]], [[prazosin]], [[probucol]], [[statins]] | |bgcolor="Beige"| [[Clofibrate]], [[Colesevelam (patient information)|colesevelam hydrochlorie]], [[colestyramine]], [[doxazosin]], [[nicotinic acid]], [[NSAID]], [[prazosin]], [[probucol]], [[statins]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 55: | Line 55: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[Abetalipoproteinemia]], [[apolipoprotein B deficiency]], [[Abetalipoproteinemia|Bassen-Kornzweig disease]], [[cystic fibrosis]], [[PCSK9#PCSK9 Deficiency|deficiency of proprotein convertase subtilisin-like/kexin type 9]], [[dyskeratosis congenita]], [[familial alphalipoprotein deficiency]], [[familial hypobetalipoproteinemia]], [[Hyperlipoproteinemia| | |bgcolor="Beige"| [[Abetalipoproteinemia]], [[apolipoprotein B deficiency]], [[Abetalipoproteinemia|Bassen-Kornzweig disease]], [[cystic fibrosis]], [[PCSK9#PCSK9 Deficiency|deficiency of proprotein convertase subtilisin-like/kexin type 9]], [[dyskeratosis congenita]], [[familial alphalipoprotein deficiency]], [[familial hypobetalipoproteinemia]], [[Hyperlipoproteinemia|familial type 5 hyperlipoproteinemia]], [[hypobetalipoproteinemia]], [[lipoprotein lipase deficiency]], [[Abetalipoproteinemia|mutations of the MTTP gene]], [[Shwachman-Diamond syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 79: | Line 79: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| [[Abetalipoproteinemia]], [[apolipoprotein B deficiency]], [[Abetalipoproteinemia|Bassen-Kornzweig disease]], [[familial alphalipoprotein deficiency]], [[familial hypobetalipoproteinemia]], [[Hyperlipoproteinemia| | |bgcolor="Beige"| [[Abetalipoproteinemia]], [[apolipoprotein B deficiency]], [[Abetalipoproteinemia|Bassen-Kornzweig disease]], [[familial alphalipoprotein deficiency]], [[familial hypobetalipoproteinemia]], [[Hyperlipoproteinemia|familial type 5 hyperlipoproteinemia]], [[hypobetalipoproteinemia]], [[lipoprotein lipase deficiency]], [[Abetalipoproteinemia|mutations of the MTTP gene]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 111: | Line 111: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| [[Acute phase proteins]], [[amyloidosis]], [[autoimmune diseases]], [[celiac disease]], [[Cytokine|inflammatory cytokines]], [[serum amyloid A]], [[Sjögren's syndrome]] | |bgcolor="Beige"| [[Acute phase proteins]], [[amyloidosis]], [[autoimmune diseases]], [[celiac disease]], [[Cytokine|inflammatory cytokines]], [[serum amyloid A|high serum amyloid A]], [[Sjögren's syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 158: | Line 158: | ||
*[[Familial hypobetalipoproteinemia]] | *[[Familial hypobetalipoproteinemia]] | ||
*[[Giardiasis]] | *[[Giardiasis]] | ||
*[[Hyperlipoproteinemia| | *[[Hyperlipoproteinemia|Familial type 5 hyperlipoproteinemia]] | ||
*[[Hypobetalipoproteinemia]] | *[[Hypobetalipoproteinemia]] | ||
*[[Cytokine|Inflammatory cytokines]] | *[[Cytokine|Inflammatory cytokines]] | ||
Line 177: | Line 177: | ||
*[[Probucol]] | *[[Probucol]] | ||
*[[Protein losing enteropathy]] | *[[Protein losing enteropathy]] | ||
*[[Serum amyloid A]] | *[[Serum amyloid A|High serum amyloid A]]<ref name="pmid23448606">{{cite journal| author=Sari I, Bakir S, Engin A, Aydin H, Poyraz O| title=Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever. | journal=Bosn J Basic Med Sci | year= 2013 | volume= 13 | issue= 1 | pages= 21-6 | pmid=23448606 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23448606 }} </ref> | ||
*[[Short bowel syndrome]] | *[[Short bowel syndrome]] | ||
*[[Shwachman-Diamond syndrome]] | *[[Shwachman-Diamond syndrome]] |
Latest revision as of 11:57, 30 October 2014
Low Density Lipoprotein Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Low LDL causes On the Web |
American Roentgen Ray Society Images of Low LDL causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Rim Halaby, M.D. [3]; Vendhan Ramanujam M.B.B.S [4]
Overview
Low LDL levels can be caused by unusual inherited disorders of lipoprotein metabolism such as abetalipoproteinemia and hypobetalipoproteinemia.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Low LDL does not have any life-threatening cause.
Common Causes
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ Scanu, AM.; Aggerbeck, LP.; Kruski, AW.; Lim, CT.; Kayden, HJ. (1974). "A study of the abnormal lipoproteins in abetalipoproteinemia". J Clin Invest. 53 (2): 440–53. doi:10.1172/JCI107578. PMID 11344558. Unknown parameter
|month=
ignored (help) - ↑ Welty, FK.; Mittleman, MA.; Wilson, PW.; Sutherland, PA.; Matheney, TH.; Lipinska, I.; Muller, JE.; Levy, D.; Tofler, GH. (1997). "Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population". Circulation. 95 (4): 825–30. PMID 9054738. Unknown parameter
|month=
ignored (help) - ↑ Sari I, Bakir S, Engin A, Aydin H, Poyraz O (2013). "Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever". Bosn J Basic Med Sci. 13 (1): 21–6. PMID 23448606.